Local dual delivery therapeutic strategies: Using biomaterials for advanced bone tissue regeneration

Taha Umair Wani,Rumysa Saleem Khan,Anjum Hamid Rather,Mushtaq A. Beigh,Faheem A. Sheikh
DOI: https://doi.org/10.1016/j.jconrel.2021.09.029
IF: 11.467
2021-11-01
Journal of Controlled Release
Abstract:Bone development is a complex process involving a vast number of growth factors and chemical substances. These factors include transforming growth factor-beta, platelet-derived growth factor, insulin-like growth factor, and most importantly, the bone morphogenetic protein, which exhibits excellent therapeutic value in bone repair. However, the spatial-temporal relationship in the expression of these factors during bone formation shaping the bone repair is a more complicated process to address. Thus, using a single therapeutic agent to address bone formation does not seem to provide a clinically effective option. Conversely, a dual delivery approach facilitating the co-delivery of agents has proved to be a dynamic alternative since such a strategy can provide more efficient spatial-temporal action. Such delivery systems can smartly target more than one pathway or differentiation lineage and thus offer more efficient bone regeneration. This review discusses various dual delivery strategies reported in the literature employed to achieve improved bone regeneration. These include concurrent use of different therapeutic agents (including growth factors and drugs), enhancing bone formation and cell recruitment, and improving the efficiency of bone healing.
pharmacology & pharmacy,chemistry, multidisciplinary
What problem does this paper attempt to address?